Given Imaging announces first centre of excellence for colon capsule
14 May 2012
Given Imaging, a world leader in specialty GI
products and pioneer of capsule endoscopy, has announced the designation
of the Policlinico Agostino Gemelli in Rome, Italy, as the first colon
capsule endoscopy (CCE) Center of Excellence (CoE).
Policlinico A. Gemelli is part of the medical school of the
Universita Cattolica del Sacro Cuore, the largest private university
in Italy. The announcement took place during the EndoLiveRoma 2012,
an international endoscopy symposium including live demonstrations
and state-of-the-art lectures.
"We are proud that the Policlinico A. Gemelli has been designated
as the first colon capsule endoscopy Center of Excellence," said
Professor Guido Costamagna, head of the Digestive Endoscopy Unit,
Universita Cattolica del Sacro Cuore, Policlinico A. Gemelli, Rome.
"Over the last four years, we have developed extensive experience in
CCE through our participation in several multicenter clinical
trials, as well as through academic endeavours such as developing the
recently published European Society for Gastrointestinal Endoscopy
(ESGE) guidelines on colon capsule endoscopy. We believe that this
makes us optimally positioned to educate other clinicians about this
valuable diagnostic tool and serve as a reference destination for
"Given Imaging is delighted to designate Policlinico A. Gemelli,
an elite healthcare organization recognized for its high quality
patient care, expert medical professionals and support of scientific
innovation, as our first Center of Excellence for colon capsule
endoscopy," said Homi Shamir, president and CEO, Given Imaging.
Gemelli continues to be a respected source for physician and nurse education
regarding colon capsule endoscopy for its colleagues around the
world. Such efforts should help to increase awareness about the role
and benefits of colon capsule endoscopy in the visualization of
colonic mucosa and expand the use of PillCam(R) COLON 2 in Europe,"
Complementary to other colon examinations, PillCam COLON 2
capsule endoscopy is the only non-invasive exam that provides direct
visualization for patients where the risks of other modalities could
outweigh the benefits. These patients include those who are at a
higher risk for complications due to cardiopulmonary disease or use
of blood thinning medications. In addition, this new technology
could provide a solution for patients that refuse colonoscopy or
those with a previous incomplete colonoscopy.
PillCam capsule endoscopes are ingestible video capsules that
enable physicians to visualize distinct portions of the GI tract.
Patient-friendly in nature, PillCam endoscopy requires no sedation
or insufflation and typically is used on an outpatient basis. With
PillCam video capsules for the esophagus, small bowel, and colon,
PillCam capsule endoscopy has been clinically validated, as
evidenced by more than 1,600 peer-reviewed publications. To date,
more than 1.5 million patients worldwide have benefited from PillCam
About PillCam COLON 2
The PillCam COLON 2 video capsule is equipped with two miniature
color video cameras (one on each end), a battery and an LED light
source; it measures 11.6 mm X 31.5 mm. PillCam COLON 2 is designed
to be ingested by the patient and transmit up to 35 frames per
second for approximately 10 hours to a recording device worn by the
patient. Data are transferred from the device to a computer that
uses RAPID software to compile the video data and enable the
physician to review and report the results of the PillCam study.
All medical procedures carry some risk. The risks of PillCam
capsule endoscopy include capsule retention, aspiration, or skin
irritation. PillCam COLON 2 capsule endoscopy presents additional
risks, including risks associated with the drug products used to
prepare the patient for the procedure, which are currently used for
colonoscopy, and to move the capsule through the patient's digestive
tract faster. It may also present other risks that are unknown.
Medical, endoscopic, or surgical intervention may be necessary to
address any of these complications, should they occur.
PillCam COLON 2 is not cleared for use in the United States and
certain other jurisdictions.